Evidence map›Paper›PMID 28498966›Full record

ArticleNucleic acids research2017

GenProBiS: web server for mapping of sequence variants to protein binding sites.

Janez Konc, Blaz Skrlj, Nika Erzen, Tanja Kunej, Dusanka Janezic

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Janez KoncNational Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
Blaz SkrljNational Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
Nika ErzenNational Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
Tanja KunejBiotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
Dusanka JanezicUniversity of Primorska, Faculty of Mathematics, Natural Sciences and Information Technologies, 6000 Koper, Slovenia.
National Institute of Chemistry · SIUniversity of Primorska · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovery of potentially deleterious sequence variants is important and has wide implications for research and generation of new hypotheses in human and veterinary medicine, and drug discovery. The GenProBiS web server maps sequence variants to protein structures from the Protein Data Bank (PDB), and further to protein-protein, protein-nucleic acid, protein-compound, and protein-metal ion binding sites. The concept of a protein-compound binding site is understood in the broadest sense, which includes glycosylation and other post-translational modification sites. Binding sites were defined by local structural comparisons of whole protein structures using the Protein Binding Sites (ProBiS) algorithm and transposition of ligands from the similar binding sites found to the query protein using the ProBiS-ligands approach with new improvements introduced in GenProBiS. Binding site surfaces were generated as three-dimensional grids encompassing the space occupied by predicted ligands. The server allows intuitive visual exploration of comprehensively mapped variants, such as human somatic mis-sense mutations related to cancer and non-synonymous single nucleotide polymorphisms from 21 species, within the predicted binding sites regions for about 80 000 PDB protein structures using fast WebGL graphics. The GenProBiS web server is open and free to all users at http://genprobis.insilab.org.

Indexed as

Genetic VariationSoftwareBinding SitesBrain NeoplasmsDatabases, ProteinEnzyme InhibitorsGenes, p53Genome-Wide Association StudyGlioblastomaHumansIndoleamine-Pyrrole 2,3,-DioxygenaseInternetLigandsMutation, MissensePolymorphism, Single NucleotideProteinsEnzyme InhibitorsIndoleamine-Pyrrole 2,3,-DioxygenaseLigandsProteins

Identifiers

PMID28498966
PMCPMC5570222
OpenAlexW2613478649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.